Related Experiment Videos
Selective T cell defects induced by dopamine administration in mice
E Kouassi1, W Boukhris, J Descotes
1INSERM U80, CNRS UA1177, UCBL, Hôpital E. Herriot, Lyon, France.
Immunopharmacology and Immunotoxicology
|January 1, 1987
Summary
Dopamine administration in mice impaired immune responses, including T cell activity and cytotoxic T cell generation. However, dopamine enhanced certain spleen cell responses, suggesting selective immune modulation.
Area of Science:
- Immunology
- Neuroscience
- Pharmacology
Background:
- Dopamine is a neurotransmitter with known immunomodulatory effects.
- The precise impact of dopamine on T cell subsets and functions requires further elucidation.
Purpose of the Study:
- To investigate the effects of dopamine administration on various T cell-mediated immune responses in BALB/c mice.
- To determine if dopamine induces selective defects or enhancements in T cell populations and their functions.
Main Methods:
- Dopamine was administered to BALB/c mice.
- Delayed-type hypersensitivity reactions and mixed-lymphocyte cultures were assessed.
- Generation of cytotoxic T cells and T cell populations in spleen and thymus were quantified.
- Spleen cell stimulation by concanavalin A and PHA was measured.
Main Results:
- Dopamine depressed delayed-type hypersensitivity, mixed-lymphocyte culture responses, cytotoxic T cell generation, and spleen T cell numbers.
- Dopamine enhanced concanavalin A-stimulated spleen cells but not PHA-stimulated cells.
- No significant effects were observed on total spleen and thymus cell counts or thymus T cell subset distribution.
Conclusions:
- Dopamine administration induces selective T cell defects.
- These defects are likely mediated by a direct peripheral action of dopamine on specific T lymphocyte subsets.
- Dopamine's immunomodulatory effects are complex and subset-specific.